tiprankstipranks
Upstream Bio, Inc. (UPB)
NASDAQ:UPB
US Market

Upstream Bio, Inc. (UPB) Similar Stocks

Compare
18 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Upstream Bio, Inc.
$7.63
$366.90M
3 Buy
0 Hold
0 Sell
Strong Buy
Viatris
$8.96
$10.68B
-19.35%
1 Buy
2 Hold
2 Sell
Hold
Nektar Therapeutics
$0.80
$149.18M
-11.00%
5 Buy
2 Hold
1 Sell
Moderate Buy
AnaptysBio
$18.19
$557.83M
-15.79%
9 Buy
2 Hold
0 Sell
Strong Buy
Kiniksa Pharmaceuticals
$22.76
$1.70B
13.97%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
UPB
Upstream Bio, Inc.
6.84
-16.54
-70.74%
VTRS
Viatris
8.96
-2.48
-21.68%
NKTR
Nektar Therapeutics
0.80
-0.13
-13.98%
ANAB
AnaptysBio
18.19
-4.33
-19.23%
KNSA
Kiniksa Pharmaceuticals
22.76
3.03
15.36%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis